Frontlight ResearchEarly access
What researchers published on Fatty liver disease (MASLD/MASH)
7,899 papers, newest first.
Showing 60 of 7,899
Integrated chemical profiling and lipidomics reveal that Mailuoning oral liquid alleviates diet-induced MASLD via PPARα-mediated lipid homeostasis and COX-2 inhibition, with identification of potential active constituents.Frontiers in pharmacology
Association between systemic immune-inflammation index and skeletal muscle mass in patients with nonalcoholic fatty liver disease: A cross-sectional study.Medicine
Tubastatin A Mitigates Lipotoxicity, Inflammation and Fibrosis Through Downregulation of HDAC6 and Modulation of AMPK-FGF21 Axis in Metabolic Dysfunction-Associated Steatohepatitis.Inflammation
Metabolic Dysfunction-Associated Steatotic Liver Disease, With and Without Increased Alcohol Intake, and Incident Atrial Fibrillation in Older Korean Adults: A Competing-Risk Cohort Study.Geriatrics & gerontology international
Associations of metabolic dysfunction-associated steatotic liver disease and cardiometabolic burden with urinary tubular biomarker abnormalities: a cross-sectional health examination study.Frontiers in medicine
Systematic reviewKetogenic Diet Effects on Liver Health in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review.Liver international : official journal of the International Association for the Study of the Liver
ReviewNutraceuticals for the prevention of liver fibrosis in metabolic dysfunction-associated steatotic liver disease (MASLD).Food science and biotechnology
ReviewCompositional diversity and dietary implications of cereal and legume crops as functional resources for non-alcoholic fatty liver disease prevention: a review.Food science and biotechnology
Association of longitudinal serum 25-hydroxyvitamin D trajectories with subsequent liver stiffness increase in patients with early-onset type 2 diabetes and metabolic dysfunction-associated steatotic liver disease.Frontiers in endocrinology
Total-Body 18F-FAPI PET/CT for Assessment of Metabolic Dysfunction-Associated Steatotic Liver Disease: A Pilot Study.Journal of nuclear medicine : official publication, Society of Nuclear Medicine
ReviewTherapeutic opportunities of fecal microbiota transplantation in the treatment of non-alcoholic fatty liver disease.Frontiers in cellular and infection microbiology
ATM safeguards liver homeostasis by mitigating mitochondrial hypermetabolism and bioenergetic crisis in MASLD.EMBO molecular medicine
Review[Research progress on male reproductive function impairment caused by metabolic dysfunction-associated steatotic liver disease].Zhonghua nan ke xue = National journal of andrology
Correction: Prevalence and steatosis severity of MASLD in patients with type 2 diabetes mellitus in Kuwait.Frontiers in endocrinology
Investigating the regulatory potential of interval training and IPA supplementation on modulating the hepatic gluconeogenesis pathway in rats with non-alcoholic fatty liver disease.BMC gastroenterology
Cognitive impairment in metabolic dysfunction-associated steatotic liver disease ‒ Clinical evidence, liver-brain mechanisms and research priorities.Revista espanola de enfermedades digestivas
ReviewFructose-related metabolic stress in MASLD: integrating intestinal substrate partitioning, hepatic phosphorus metabolite dynamics, and the inflammatory-fibrotic interface.Frontiers in medicine
A Minimally Invasive Diagnostic Platform Compatible with Tissue and Serum Analysis for Early Detection of Non-Alcoholic Fatty Liver Disease.Analytical chemistry
Joint effects of phenotypic age acceleration and novel insulin resistance indicators on mortality in adults with metabolic dysfunction-associated steatotic liver disease: a prospective cohort study.Cardiovascular diabetology
Machine learning-based prediction of non-alcoholic fatty liver disease in Chinese perimenopausal women: a retrospective observational study.BMJ open
Changing etiological spectrum and the rise of metabolic risk in liver cancer burden in China (1990-2021) with projections to 2036: a decomposition analysis based on the GBD 2021 study.BMC cancer
An Enzyme-Triggered Self-Immobilizing Dual-Modal Probe for Precision Imaging and Sustained Gas Therapy of Early-Stage MASH.Analytical chemistry
ReviewPredicting response to GLP-1-based therapy in MASLD/MASH: an evidence-tiered, endpoint-specific framework built on host genotype and gut microbial features.Frontiers in endocrinology
Safety and efficacy of weekly pemvidutide versus placebo for metabolic dysfunction-associated steatohepatitis (IMPACT): 48-week results from a multicentre, randomised, double-blind, phase 2b study.The lancet. Gastroenterology & hepatology
Associations of cumulative exposure and dynamic trajectories of the normalized creatinine-to-cystatin C ratio with incident cardiovascular disease in middle-aged and older Chinese adults with metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study.BMC cardiovascular disorders
Biological sex modifies the link between nutrient intake and metabolic dysfunction-associated steatotic liver disease: intrinsic oxidative vulnerability in females.Journal of the Endocrine Society
GLP-1-based Therapies in MASH: From Metabolic Benefits to an Improvement in Liver Fibrosis.Internal medicine (Tokyo, Japan)
Systematic reviewPolyamine Dysregulation in Metabolic Dysfunction-associated Steatotic Liver Disease: a Systematic Review of Human Observational Evidence.Current obesity reports
Claims-defined hepatic steatosis compatible with MASLD and reproductive outcomes after the first observed embryo transfer: a Korean nationwide cohort study.BMC gastroenterology
Decoding Mitochondrial CircRNA Dynamics with In Situ Super-Resolution Bioimaging and Quantification via a Ratiometric DNA Tetrahedral Amplifier.Analytical chemistry
Elevated Risk of Bladder Cancer Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease in Elderly Korean Men: A Nationwide Cohort Study.Journal of Korean medical science
ReviewHepatocyte-derived lipid droplets in MASH: macrophage sensing and inflammation.Frontiers in immunology
Conventional Preoperative Prediction of MASLD-Compatible Histologic Abnormality, Fibrosis, and Higher-Grade Steatohepatitis, and Exploratory Machine-Learning Classification of MASH Severity in Patients Undergoing Roux-en-Y Gastric Bypass.Obesity surgery
Longitudinal Changes in Physical Performance with Metabolic Dysfunction-Associated Steatotic Liver Disease and Coronary Artery Disease.Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association
Unresolved questions for nutrient-stimulated hormonal multi-agonists in MASH; more receptors, better livers?: Editorial on "Engineered nutrient-stimulated hormonal multi-agonists for precision targeting of obesity and metabolic disorders".Clinical and molecular hepatology
ReviewDietary interventions in metabolic dysfunction-associated steatotic liver disease: current evidence, research priorities, and clinical translation.Clinical and experimental hepatology
Liquiritigenin Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK-Mediated Dual Activation of PPARα/PPARγ.Food science & nutrition
Elevated circulating activin A is associated with disease severity in advanced steatotic liver disease (SLD).BMC gastroenterology
Neuro-immune and metabolic disorders in association with depression, anxiety, and chronic fatigue-fibromyalgia symptoms due to nonalcoholic fatty liver disease.CNS spectrums
Case reportGlycogenic Hepatopathy Mimicking Overlapping with Metabolic Dysfunction-Associated Steatotic Liver Disease in Newly Diagnosed Type 2 Diabetes: A Case Report.SAGE open medical case reports
Comment on "Effect of High Dose N-Acetyl Cysteine Supplementation on Markers of Oxidative Stress and Insulin Resistance in Non-Diabetic Patients With Metabolic Dysfunction Associated Steatotic Liver Disease: A Randomized Controlled Trial".Journal of gastroenterology and hepatology
3β-trans-CLD alleviates metabolic dysfunction-associated steatotic liver disease (MASLD) via modulating the IDO1/Nrf2/SREBP1/SCD1 axis in vitro.Fitoterapia
ReviewEffects of Bacterial-Derived Extracellular Vesicles in Rodent Models of Obesity, Metabolic Dysfunction-Associated Steatotic Liver Disease and Insulin Resistance/type 2 Diabetes. A Systematic Review.Probiotics and antimicrobial proteins
Propolis Supplementation in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.Phytotherapy research : PTR
DTC1225, a novel benzothiazole-based compound, ameliorates MASLD by restoring metabolic-redox homeostasis and promoting hepatic lipid remodeling.Metabolism: clinical and experimental
Numerical reproducibility and threshold interpretation in MASLD risk stratification.Clinical and molecular hepatology
Letter to the Editor on "Normal-weight MASLD: reclassification, characteristics, and adverse liver outcomes across diverse populations".Clinical and molecular hepatology
Efinopegdutide: a step towards precision in MASH therapy?Lancet (London, England)
What Does Normal BMI Hide in MASLD? Body Composition and Cause-Specific Mortality After Reclassification: Authors' reply.Clinical and molecular hepatology
GLP-1/Glucagon Receptor Dual Agonists for Metabolic Dysfunction-Associated Steatohepatitis and Steatotic Liver Disease (MASH/MASLD): A Systematic Review and Meta-Analysis.Digestive diseases (Basel, Switzerland)
TMEM189/PEDS1 deficiency aggravates MASH progression by promoting FASN-mediated macrophage activation.Cell death & disease
Clarifying local price mapping, response thresholds, and re-treatment structure in MASLD cost-effectiveness modeling.Clinical and molecular hepatology
Saroglitazar Facilitates Insulin De-escalation and Improves Metabolic Parameters in Pioglitazone-Ineligible Non-metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Type 2 Diabetes: Real-World Evidence From India.Cureus
Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Letter to the editor on "Aspirin and hepatocellular carcinoma risk in metabolic dysfunction-associated steatotic liver disease: Nationwide cohort study with genetic risk analysis".Clinical and molecular hepatology
A Liver-Targeted CIDEB siRNA in Adults with MASLD.The New England journal of medicine
Reply: Thoughts on the clinical translation of dynamic fibrosis risk assessment models in MASLD.Clinical and molecular hepatology
Efficacy and safety of efinopegdutide in adults with metabolic dysfunction-associated steatohepatitis and stage 2-3 fibrosis: a phase 2b, randomised, placebo-controlled study.Lancet (London, England)
Sex-Specific Risk Thresholds of Binge-Drinking Frequency for Advanced Fibrosis in MetALD and ALD: Analysis of the NHANES Cohort.Alcohol, clinical & experimental research
Correspondence on reply to "Quantitative fragility of reported association between aspirin use and hepatocellular carcinoma risk in MASLD".Clinical and molecular hepatology
Beyond BMI in MASLD: Rethinking Lean Phenotypes and Metabolic Risk Stratification: Authors' reply.Clinical and molecular hepatology